Key result
Men with metabolic syndrome show ~19% lower myocardial energetic efficiency and worse GLS than women.
Why the study?
Metabolic and hemodynamic alterations in metabolic syndrome (MetS) can reduce myocardial energetic efficiency (MEE), but the impact of MetS on MEE and systolic strain across sexes remains to be evaluated.
Does metabolic syndrome impair myocardial energetic efficiency and global longitudinal strain, and are there sex differences in these alterations?
Observational (n=238)
Does metabolic syndrome impair myocardial energetic efficiency and global longitudinal strain, and are there sex differences in these alterations?
Absolute Event Rate: 0.68% vs 0.84%
p-value: p=<0.05
Metabolic syndrome impairs myocardial energetic efficiency and global longitudinal strain even without overt systolic dysfunction, with men experiencing more severe alterations than women.
Men with metabolic syndrome exhibit greater myocardial impairment than women; this Level 3 cohort finding leaves open sex-specific prognostic and therapeutic implications.
Background Metabolic and hemodynamic alterations in metabolic syndrome (MetS) can cause a reduced myocardial energetic efficiency (MEE). Indexed MEE (MEEi), as a simple estimate of MEE, is emerging as a novel and useful imaging parameter. Purpose To investigate the impact of MetS on MEE and systolic myocardial strain and to assess any sex difference. Study type Retrospective. Population A total of 161 patients with MetS (female: n = 82, 52.2 ± 11.7 years; male: n = 79, 51.8 ± 10.6 years) and 77 healthy subjects (female: n = 46, 52.7 ± 8.2 years; male: n = 31, 54.1 ± 11.2 years). Patients with left ventricular (LV) ejection fraction <50% were excluded. Field Strength/Sequence A 3.0 T; balanced steady‐state free precession sequence. Assessment LV volumes and mass (LVM) and global longitudinal strain (GLS) were obtained by MRI. Stroke volume (SV) divided by HR was used as a surrogate measure of MEE and normalized to LVM (MEEi). Statistical Tests Student's t ‐test or Mann–Whitney U ‐test; Multivariable linear regression (coefficient of determination, R 2 ). P < 0.05 was considered statistically significant. Results For both males and females, MEEi and GLS were lower in MetS patients than in the normal controls. Among MetS patients, men had significantly higher LVM (59.7 ± 13.4 g/m 2 vs. 48.8 ± 11.3 g/m 2 ) and significantly lower MEEi (0.68 ± 0.23 mL/g/s vs. 0.84 ± 0.23 mL/g/s) and GLS (−11.7% ± 2.8% vs. −13.9% ± 2.7%) than women. After adjustment for clinical variables, male gender ( β = −0.291) was found to be inversely correlated with MEEi. Multivariable analysis showed that MEEi ( β = 0.454) were independently associated with GLS (adjusted R 2 = 0.454) after adjustment for clinical and other MRI parameters. Data Conclusion MEEi was significantly impaired in MetS without overt systolic dysfunction. There was a sex difference regarding the cardiac alterations in MetS, with men having significantly lower MEEi and GLS and significantly higher LVM than women. Further, MEEi was independently associated with GLS.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2022) conducted an observational in Metabolic syndrome (n=238). Male sex (in metabolic syndrome) vs. Female sex (in metabolic syndrome) was evaluated on Indexed myocardial energetic efficiency (MEEi) (p=<0.05). Among patients with metabolic syndrome, men had significantly lower indexed myocardial energetic efficiency (0.68 vs. 0.84 mL/g/s) and global longitudinal strain (-11.7% vs. -13.9%) compared to women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: